Development status: Experimental

Gram-positive activity

Mechanism of Action/Target pathogen: Activity against Clostridioides difficile, Neisseria gonorrhoeae and Haemophilus influenzae

Additional information: Natural product produced by Streptomyces; total synthesis; structurally related to nodusmicin, nargenicin and branimycin